Co-producing Human and Animal Experimental Subjects: Exploring the Views of UK COVID-19 Vaccine Trial Participants on Animal Testing
- PMID: 37529348
- PMCID: PMC10387720
- DOI: 10.1177/01622439211057084
Co-producing Human and Animal Experimental Subjects: Exploring the Views of UK COVID-19 Vaccine Trial Participants on Animal Testing
Abstract
Preclinical (animal) testing and human testing of drugs and vaccines are rarely considered by social scientists side by side. Where this is done, it is typically for theoretically exploring the ethics of the two situations to compare relative treatment. In contrast, we empirically explore how human clinical trial participants understand the role of animal test subjects in vaccine development. Furthermore, social science research has only concentrated on broad public opinion and the views of patients about animal research, whereas we explore the views of a public group particularly implicated in pharmaceutical development: experimental subjects. We surveyed and interviewed COVID-19 vaccine trial participants in Oxford, UK, on their views about taking part in a vaccine trial and the role of animals in trials. We found that trial participants mirrored assumptions about legitimate reasons for animal testing embedded in regulation and provided insight into (i) the nuances of public opinion on animal research; (ii) the co-production of human and animal experimental subjects; (iii) how vaccine and medicine testing, and the motivations and demographics of clinical trial participants, change in an outbreak; and (iv) what public involvement can offer to science.
Keywords: COVID-19; animal research; clinical trial; co-production; vaccine.
© The Author(s) 2021.
Conflict of interest statement
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures
References
-
- Abadie Roberto. 2010. The Professional Guinea Pig: Big Pharma and the Risky World of Human Subjects. Durham, NC: Duke University Press.
-
- Animals in Science Committee. 2017. Review of Harm-benefit Analysis in the Use of Animals in Research. London, UK: Home Office.
-
- Aronczyk Melissa. 2013. “Market(ing) Activism: Lush Cosmetics, Ethical Oil, and the Self-mediation of Protest.” Journalism Media and Cultural Studies Journal 4 (2013): 1–21. doi: 10.18573/j.2013.10256.
-
- Ball Philip. 2020. “The Lightning-fast Quest for COVID Vaccines—And What It Means for Other Diseases.” Nature 589 (7840): 16–18. doi: 10.1038/d41586-020-03626-1. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources